Where are the proposals to reinvigorate the London Stock Exchange and boost both public and private UK equity markets?
An expert panel discussed their view of global trends for the business world as the end of 2023 draws nearer.
Learning lessons from the CBI; US say-on-climate voting enthusiasm dims; calls for higher executive pay… and for pay restraint.
Boards in the pharmaceutical and life sciences sector face increasingly difficult decisions, according to a recent Board Agenda podcast.
Why right now is the best time for boards to make contact with politicians who can impact—or potentially impact—your business’s bottom line.